Cited by 758Pluripotent Stem Cells ResearchOrgan and Tissue Transplantation ResearchMesenchymal stem cell research

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients

Open access

Deuse, Tobias, Hu, Xiaomeng, Gravina, Alessia, Wang, Dong, Tediashvili, Grigol, De, Chandrav, Thayer, William O., Wahl, Angela, Garcia, J. Victor, Reichenspurner, Hermann, Davis, Mark M., Lanier, Lewis L., Schrepfer, Sonja·2019·Nature Biotechnology

DOI 10.1038/s41587-019-0016-3PMC PMC6419516

Open this paper in CoChat — free account

Abstract

Autologous induced pluripotent stem cells (iPSCs) constitute an unlimited cell source for patient-specific cell-based organ repair strategies. However, their generation and subsequent differentiation into specific cells or tissues entail cell line-specific manufacturing challenges and form a lengthy process that precludes acute treatment modalities. These shortcomings could be overcome by using prefabricated allogeneic cell or tissue products, but the vigorous immune response against histo-incompatible cells has prevented the successful implementation of this approach. Here we show that both mouse and human iPSCs lose their immunogenicity when major histocompatibility complex (MHC) class I and II genes are inactivated and CD47 is over-expressed. These hypoimmunogenic iPSCs retain their pluripotent stem cell potential and differentiation capacity. Endothelial cells, smooth muscle cells, and cardiomyocytes derived from hypoimmunogenic mouse or human iPSCs reliably evade immune rejection in fully MHC-mismatched allogeneic recipients and survive long-term without the use of immunosuppression. These findings suggest that hypoimmunogenic cell grafts can be engineered for universal transplantation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41587-019-0016-3

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578
Humanized mice in translational biomedical research
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature reviews. Immunology · doi:10.1038/nri2017 · Cited by 1,393
Humanized mice in translational biomedical research
Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036
Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts
Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., Ogasawara, T., Okada, K., Shiba, N., Sakamoto, K., et al. (2016) · Nature · doi:10.1038/nature19815 · Cited by 840
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1
Melkus, M. W., Estes, J. D., Padgett‐Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., Wege, A. K., Haase, A. T., & Garcia, J. V. (2006) · Nature Medicine · doi:10.1038/nm1431 · Cited by 653
Self-citation
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Gornalusse, G. G., Hirata, R. K., Funk, S. E., Riolobos, L., Lopes, V. S., Manske, G., Prunkard, D., Colunga, A. G., Hanafi, L.-A., Clegg, D. O., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3860 · Cited by 639
Fetomaternal immune cross-talk and its consequences for maternal and offspring's health
Arck, P., & Hecher, K. (2013) · Nature Medicine · doi:10.1038/nm.3160 · Cited by 609
AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
Wunderlich, M., Chou, F.-S., Link, K. A., Mizukawa, B., Perry, R. L., Carroll, M., & Mulloy, J. C. (2010) · Leukemia · doi:10.1038/leu.2010.158 · Cited by 415
Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes
Chang, C., Fontes, J., Peterlin, M., & Flavell, R. (1994) · Journal of Experimental Medicine · doi:10.1084/jem.180.4.1367 · Cited by 352
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in Patients With Acute Myocardial Infarction Based on Individual Patient Data
Gyöngyösi, M., Wojakowski, W., Lemarchand, P., Lunde, K., Tendera, M., Bartunek, J., Marbán, E., Aßmus, B., Henry, T. D., Traverse, J. H., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.304346 · Cited by 313

Show all 31 references

Sorted by citations

Items 301–400 of 758

Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing.
Bogomiakova, M., Sekretova, E. K., Eremeev, A., Shuvalova, L. D., Bobrovsky, P. A., Zerkalenkova, E. A., Lebedeva, O., & Lagarkova, M. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102451 · Cited by 16
Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer
Polten, R., Kutle, I., Hachenberg, J., Klapdor, R., Morgan, M. A., & Schambach, A. (2022) · Cancers · doi:10.3390/cancers15010263 · Cited by 18
In vitro oxygen imaging of acellular and cell-loaded beta cell replacement devices
Kotecha, M., Wang, L., Hameed, S., Viswakarma, N., Ma, M., Stabler, C. L., Hoesli, C. A., & Epel, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-42099-w · Cited by 17
Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
Caldara, R., Tomajer, V., Monti, P., Sordi, V., Citro, A., Chimienti, R., Gremizzi, C., Catarinella, D., Tentori, S., Paloschi, V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1323439 · Cited by 19
Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery
Lansberry, T. R., & Stabler, C. L. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115179 · Cited by 20
Induced pluripotent stem cells as a novel cancer vaccine
Wang, L., Pegram, M. D., & Wu, J. C. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1650909 · Cited by 18
Human iPS Cell-derived Tissue Engineered Vascular Graft: Recent Advances and Future Directions
Shi, X., He, L., Zhang, S., & Luo, J. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10091-w · Cited by 18
Application of decellularization methods for scaffold production: advantages, disadvantages, biosafety and modifications
Shevchuk, O. I., Korcheva, V., Moskalenko, N. S., Kyryk, V. M., Kot, K., & Krasnienkov, D. S. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1621641 · Cited by 20
Extracellular Matrix for Small-Diameter Vascular Grafts
Kimicata, M., Swamykumar, P., & Fisher, J. P. (2020) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0201 · Cited by 17
One Billion hiPSC-Cardiomyocytes: Upscaling Engineered Cardiac Tissues to Create High Cell Density Therapies for Clinical Translation in Heart Regeneration
Dwyer, K. D., Kant, R. J., Soepriatna, A. H., Roser, S. M., Daley, M. C., Sabe, S. A., Xu, C., Choi, B., Sellke, F. W., & Coulombe, K. L. K. (2023) · Bioengineering · doi:10.3390/bioengineering10050587 · Cited by 17
Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations
Chen, C., & Guan, M. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00967-7 · Cited by 18
Pluripotent stem cell-based cardiac regenerative therapy for heart failure
Soma, Y., Tani, H., Morita-Umei, Y., Kishino, Y., Fukuda, K., & Tohyama, S. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.12.001 · Cited by 17
Toward a Universal Solution: Editing Compatibility into Pluripotent Stem Cells
Trounson, A., Boyd, N. R., & Boyd, R. L. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.03.003 · Cited by 17
Current Challenges and Solutions to Tissue Engineering of Large-scale Cardiac Constructs
Chang, Y., Mirhaidari, G. J. M., Kelly, J. M., & Breuer, C. K. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01474-7 · Cited by 17
In vitro vascularization improves in vivo functionality of human engineered cardiac tissues
Li, H., Shadrin, I. Y., Helfer, A., Heman, K. L., Rao, L., Curtis, C., Palmer, G. M., & Bursac, N. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.11.014 · Cited by 18
Clinical perspective on pluripotent stem cells derived cell therapies for the treatment of neurodegenerative diseases
Izrael, M., Chebath, J., Molakandov, K., & Revel, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115525 · Cited by 17
Off-the-Shelf Chimeric Antigen Receptor T Cells
Watanabe, N., & Mamonkin, M. (2021) · The Cancer Journal · doi:10.1097/ppo.0000000000000511 · Cited by 17
Advances in Manufacturing Cardiomyocytes from Human Pluripotent Stem Cells
Floy, M. E., Shabnam, F., Simmons, A. D., Bhute, V. J., Jin, G., Friedrich, W. A., Steinberg, A. B., & Palecek, S. P. (2022) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-092120-033922 · Cited by 16
Culturing human pluripotent stem cells for regenerative medicine
Ozawa, H., Matsumoto, T., & Nakagawa, M. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2225701 · Cited by 16
The Dawn of In Vivo Gene Editing Era: A Revolution in the Making
Niazi, S. K. (2023) · Biologics · doi:10.3390/biologics3040014 · Cited by 17
Graft survival of major histocompatibility complex deficient stem cell-derived retinal cells
Ishida, M., Masuda, T., Sakai, N., Nakai-Futatsugi, Y., Kamao, H., Shiina, T., Takahashi, M., & Sugita, S. (2024) · Communications Medicine · doi:10.1038/s43856-024-00617-5 · Cited by 14
Pluripotent stem cell-based gene therapy approach: human de novo synthesized chromosomes
Sinenko, S. A., Ponomartsev, S. V., & Tomilin, A. N. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03653-1 · Cited by 16
Off-the-Shelf, Immune-Compatible Human Embryonic Stem Cells Generated Via CRISPR-Mediated Genome Editing
Kim, A., Lee, K., Kwon, Y., Lee, K.-I., Yang, H.-M., Habib, O., Kim, J., Kim, S. J., Kim, J., Kim, J., et al. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10113-7 · Cited by 17
Human muscle production in vitro from pluripotent stem cells: Basic and clinical applications
Yan, L., Rodríguez‐delaRosa, A., & Pourquié, O. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.04.017 · Cited by 18
Regulatory T cells and transplantation tolerance: Emerging from the darkness?
Waldmann, H. (2021) · European Journal of Immunology · doi:10.1002/eji.202048795 · Cited by 16
Is hypoimmunogenic stem cell therapy safe in times of pandemics?
Matheus, F., Raveh, T. B., Oro, A. E., Wernig, M., & Drukker, M. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.02.014 · Cited by 15
CRISPR/Cas9 Ribonucleoprotein Complex-Mediated Efficient B2M Knockout in Human Induced Pluripotent Stem Cells (iPSCs).
Thongsin, N., & Wattanapanitch, M. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_352 · Cited by 14
Future potential of engineered heart tissue patches for repairing the damage caused by heart attacks
Jabbour, R. J., Owen, T. J., Pandey, P., & Harding, S. E. (2019) · Expert Review of Medical Devices · doi:10.1080/17434440.2020.1700793 · Cited by 16
Human iPSCs-derived mesenchymal stem cells promote skin regeneration and burn wound healing
Farahat, M., Brosset, S., Chen, Y. A., Aijaz, A., Rix, G., Challagundla, B., Elloso, M. S., Hutter, M. F., Rogers, I. M., & Jeschke, M. G. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00427-w · Cited by 15
Clinical considerations in Parkinson’s disease cell therapy
Xue, J., Wu, Y., Bao, Y., Zhao, M., Li, F., Sun, J., Sun, Y., Wang, J., Chen, L., Mao, Y. Q., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101792 · Cited by 16
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect
An, Y., Jin, X. K., Zhang, H., Zhang, M., Mahara, S., Lu, W., & Zhao, M. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01061-8 · Cited by 15
Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine
Trionfini, P., Romano, E., Varinelli, M., Longaretti, L., Rizzo, P., Giampietro, R., Caroli, A., Aiello, S., Todeschini, M., Casiraghi, F., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411810 · Cited by 17
Regeneration of joint surface defects by transplantation of allogeneic cartilage: application of iPS cell-derived cartilage and immunogenicity
Abe, K., & Tsumaki, N. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00307-0 · Cited by 15
Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases
Bruno, A., Milillo, C., Anaclerio, F., Buccolini, C., Dell’Elice, A., Angilletta, I., Gatta, M., Ballerini, P., & Antonucci, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020976 · Cited by 16
Advancements and Challenges in Immune Protection Strategies for Islet Transplantation
Wang, X., Zeng, Z., Li, D., Wang, K., Zhang, W., Yu, Y., & Wang, X. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70048 · Cited by 18
Improved therapeutic consistency and efficacy of mesenchymal stem cells expanded with chemically defined medium for systemic lupus erythematosus
Xu, J., Lian, W., Wu, H., Wang, X., Chen, J., Yang, L., Zhuang, X., Li, L., & Huang, Z. W. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0364-4 · Cited by 15
Improving cell survival and engraftment in vivo via layer-by-layer nanocoating of hESC-derived RPE cells
Ru, L., Wu, N., Wei, K., Zeng, Y., Li, Q., Weng, C., Ren, C., Ren, B., Huo, D., Li, Y., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01986-z · Cited by 15
Self-citation
Generation of Monkey Induced Pluripotent Stem Cell-Derived Cartilage Lacking Major Histocompatibility Complex Class I Molecules on the Cell Surface
Okutani, Y., Abe, K., Yamashita, A., Morioka, M., Matsuda, S., & Tsumaki, N. (2021) · Tissue Engineering Part A · doi:10.1089/ten.tea.2021.0053 · Cited by 16
T Cell Development and Responses in Human Immune System Mice
Maharlooei, M. K., Li, H. W., & Sykes, M. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082223-041615 · Cited by 14
Cardiomyocytes in Hypoxia: Cellular Responses and Implications for Cell-Based Cardiac Regenerative Therapies
Dwyer, K. D., Snyder, C. A., & Coulombe, K. L. K. (2025) · Bioengineering · doi:10.3390/bioengineering12020154 · Cited by 16
Immune-evasive beta cells in type 1 diabetes: innovations in genetic engineering, biomaterials, and computational modeling
Karaoğlu, İ. C., Duymaz, D., Rashid, M. M., & Kızılel, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1618086 · Cited by 15
Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Scientist’s Perspective
Tomishima, M. J., & Kirkeby, A. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212685 · Cited by 13
Small-Caliber Tissue-Engineered Vascular Grafts Based on Human-Induced Pluripotent Stem Cells: Progress and Challenges
Ji, J., Hongju, X., Li, C., & Luo, J. (2023) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2023.0005 · Cited by 14
Expression of a mutant CD47 protects against phagocytosis without inducing cell death or inhibiting angiogenesis
Xu, L., Wang, X., Zhang, T., Meng, X., Zhao, W., Pi, C., & Yang, Y. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101450 · Cited by 14
Recent progress in modeling and treating diabetes using stem cell-derived islets
Maestas, M. M., Bui, M. H., & Millman, J. R. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae059 · Cited by 14
Cell-Based Therapeutic Approaches for Cystic Fibrosis
Duchesneau, P., Waddell, T. K., & Karoubi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155219 · Cited by 14
Epigallocatechin gallate facilitates extracellular elastin fiber formation in induced pluripotent stem cell derived vascular smooth muscle cells for tissue engineering
Ellis, M. W., Riaz, M., Huang, Y., Anderson, C. W., Luo, J., Park, J., Lopez, C. A., Batty, L. D., Gibson, K. H., & Qyang, Y. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.12.014 · Cited by 14
Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury
Gunasekaran, M., Mishra, R., Saha, P., Morales, D. L. S., Cheng, W., Jayaraman, A. R., Hoffman, J. R., Davidson, L., Chen, L., Shah, A., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104656 · Cited by 14
Self-citation
Neonatal islets from human PD-L1 transgenic pigs reduce immune cell activation and cellular rejection in humanized nonobese diabetic-scid IL2rγnull mice
Lei, Y., Buerck, L. W., Honarpisheh, M. M., Zhang, Y., Schwinzer, R., Petersen, B., & Seißler, J. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.08.026 · Cited by 14
Gene Delivery to Human Limbal Stem Cells Using Viral Vectors
Song, L., Song, Z., Fry, N. J., Conatser, L., Llanga, T., Mei, H., Kafri, T., & Hirsch, M. L. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.071 · Cited by 13
Targeting cell plasticity for regeneration: From in vitro to in vivo reprogramming
Romanazzo, S., Lin, K., Srivastava, P., & Kilian, K. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.08.007 · Cited by 15
iPSC-derived T cells and macrophages: Manufacturing and next-generation application approaches
Basílio-Queirós, D., Rivière, I., van der Stegen, S. J. C., & Lachmann, N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115713 · Cited by 13
The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation
Cianflone, E., Scalise, M., Marino, F., Salerno, L., Salerno, N., Urbanek, K., & Torella, D. (2022) · Clinical Science · doi:10.1042/cs20220391 · Cited by 14
Generation of antigen-specific mature T cells from RAG1−/−RAG2−/−B2M−/− stem cells by engineering their microenvironment
Chang, P. C., Yuan, X., Zampieri, A., Towns, C., Yoo, S. P., Engstrom, C., Tsai, S. C., Robles, C. R., Zhu, Y., Lopez, S., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01146-7 · Cited by 12
Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle
Maheshwari, S., Akram, H., Bulstrode, H. J. C. J., Kalia, S. K., Morizane, A., Takahashi, J. B., & Natalwala, A. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230328 · Cited by 14
Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research
Bellotti, C., Samudyata, S., Thams, S., Sellgren, C. M., & Rostami, E. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01845-5 · Cited by 12
Downregulating human leucocyte antigens on mesenchymal stromal cells by epigenetically repressing a β2-microglobulin super-enhancer
Wang, F., Li, R., Xu, J. Y., Bai, X., Wang, Y., Chen, X., Chen, P., Chen, S., Zhou, K., Heng, B. C., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01264-w · Cited by 15
Long-term machine perfusion of human split livers: a new model for regenerative and translational research
Lau, N., McCaughan, G. W., Ly, M., Liu, K., Crawford, M., & Pulitanò, C. (2024) · Nature Communications · doi:10.1038/s41467-024-54024-4 · Cited by 15
Stem cell therapy in Alzheimer’s disease: current status and perspectives
Ou, C.-M., Xue, W.-W., Liu, D., Ma, L., Xie, H.-T., & Ning, K. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1440334 · Cited by 16
Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
Antao, A. M., Karapurkar, J. K., Lee, D. R., Kim, K.-S., & Ramakrishna, S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.026 · Cited by 14
hESC-derived immune suppressive dendritic cells induce immune tolerance of parental hESC-derived allografts
Todorova, D., Zhang, Y., Chen, Q., Liu, J., He, J., Fu, X., & Xu, Y. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103120 · Cited by 14
Transmural myocardial repair with engineered heart muscle in a rat model of heterotopic heart transplantation – A proof-of-concept study
Jebran, A. F., Tiburcy, M., Biermann, D., Balfanz, P., Didié, M., Karikkineth, B. C., Schöndube, F. A., Kutschka, I., & Zimmermann, W. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.03.013 · Cited by 14
New Prospects for Retinal Pigment Epithelium Transplantation
Gullapalli, V. K., & Zarbin, M. A. (2022) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000521 · Cited by 13
CAR NK-92 cell–mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products
Kath, J., Du, W., Martini, S., Elsallab, M., Franke, C., Hartmann, L. M., Drosdek, V., Glaser, V., Stein, M., Schmueck‐Henneresse, M., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009397 · Cited by 12
A Primer on Human Brain Organoids for the Neurosurgeon
Blue, R., Miranda, S. P., Gu, B. J., & Chen, H. I. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa171 · Cited by 13
Stem Cells Treatment for Wilson Disease
Zheng, S., Tang, S., Bai, L., & Duan, Z. (2021) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666211006111556 · Cited by 12
The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells
Soma, Y., Morita, Y., Kishino, Y., Kanazawa, H., Fukuda, K., & Tohyama, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.774389 · Cited by 13
Exploring Orthopedic Stem-Cell Approaches for Osteoarthritis Management: Current Trends and Future Horizons
Ehioghae, M., Vippa, T. K., Askins, D. H., Slusarczyk, S. M., Bobo, E., Montoya, A., Anderson, D. J., Robinson, C. L., Kaye, A. D., & Urits, I. (2023) · Current Pain and Headache Reports · doi:10.1007/s11916-023-01191-6 · Cited by 12
From stem cells to pancreatic β-cells: strategies, applications, and potential treatments for diabetes
Feng, X., Zhang, H., Yang, S., Cui, D., Wu, Y., Qi, X., & Su, Z. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04999-x · Cited by 13
Transient characteristics of universal cells on human‐induced pluripotent stem cells and their differentiated cells derived from foetal stem cells with mixed donor sources
Sung, T.-C., Jiang, Y.-P., Hsu, J.-Y., Ling, Q.-D., Chen, H., Kumar, S., Chang, Y., Hsu, S.-T., Ye, Q., & Higuchi, A. (2021) · Cell Proliferation · doi:10.1111/cpr.12995 · Cited by 8
iPSCs and Exosomes: Partners in Crime Fighting Cardiovascular Diseases
Germena, G., & Hinkel, R. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060529 · Cited by 12
Optimizing Generation of Stem Cell-Derived Islet Cells
Verhoeff, K. K., Cuesta‐Gomez, N., Jasra, I. T., Marfil‐Garza, B. A., Dadheech, N., & Shapiro, A. M. J. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10391-3 · Cited by 11
Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions
Garbern, J. C., Escalante, G. O., & Lee, R. T. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.01.002 · Cited by 12
Humanized Mouse Models for Evaluation of PSC Immunogenicity
Hermsen, J., & Brown, M. E. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.113 · Cited by 11
Scaffold-free cell sheet therapies: clinical advances, global approval landscapes, and strategic directions to address regenerative medicine barriers
An, L., Yuan, S., Cheng, L., Huo, F., Yang, C., & Tian, W. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04818-0 · Cited by 14
Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cell therapies
Kawamoto, H., & Masuda, K. (2024) · International Immunology · doi:10.1093/intimm/dxad051 · Cited by 11
Neutrophils, an emerging new therapeutic platform
López-Arredondo, A., Cruz-Cárdenas, J. A., Cázares-Preciado, J. A., Timmins, N. E., & Brunck, M. E. G. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103106 · Cited by 12
Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson’s disease: Insights from non-human primate studies
Emborg, M. E., Metzger, J. M., D’Amour, K. A., Colwell, J. C., Neumann, L., Zhang, A., & Federoff, H. J. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111297 · Cited by 11
Enhancing Matured Stem-Cardiac Cell Generation and Transplantation: A Novel Strategy for Heart Failure Therapy
Jackson, A. O., Rahman, G. A., Kai, Y., & Long, S. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10085-6 · Cited by 12
Generating universal chimeric antigen receptor expressing cell products from induced pluripotent stem cells: beyond the autologous CAR-T cells
Deng, X. L., Zhou, J., & Cao, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002513 · Cited by 11
Universally non-immunogenic iPSCs
Shani, T., & Hanna, J. H. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0401-8 · Cited by 11
Deconstructing Neurogenesis, Transplantation and Genome-Editing as Neural Repair Strategies in Brain Disease
Chohan, M. O. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00116 · Cited by 11
Establishment of Immune-Evasive iPSCs from PBMCs Using B2M Knockout and CD47/HLA-E Overexpression
Kim, C. Y., Jeong, C., Jeong, Y.-J., Sung, Y. H., Han, Y., & Hwang, C. (2025) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-025-00742-9 · Cited by 10
Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS
Zhang, H.-W., Zhou, H.-X., Xia, X.-G., Cao, Q.-L., & Liu, Y. (2025) · Cells · doi:10.3390/cells14161248 · Cited by 10
Microneedle-mediated exosome delivery: a precision strategy in advanced regenerative medicine
Chen, X., Gu, Q., Liu, L., Jin, A., Jia, Z., Yu, Y., Lei, L., Zhang, Q., & Li, Y. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01566a · Cited by 10
Nanoparticle-Mediated Nose-to-Brain Delivery for Ischemic Stroke Therapy: Preclinical Insights
Park, J., & Riew, T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111447 · Cited by 10
Applications, challenges, and prospects of induced pluripotent stem cells for vascular disease
Biswas, P. K., & Park, J. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100077 · Cited by 12
Human pluripotent stem cell-based cardiac repair: Lessons learned and challenges ahead
Montague, E. C., Ozcan, B., Sefton, E., Wulkan, F., Alibhai, F. J., & Laflamme, M. A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115594 · Cited by 11
Islet Transplantation: Microencapsulation, Nanoencapsulation, and Hypoimmune Engineering
Lee, K., Vargas, A. A., Bottino, R., & Wang, Y. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70016 · Cited by 12
Pluripotent stem cell-based approaches for heart repair and the potential of genetic modifications
Dulak, J., Zieliński, T., Józkowicz, A., & Łoboda, A. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.07.009 · Cited by 12
Therapeutic effects of hypoimmunogenic universal human iPSC-derived endothelial cells in a humanized mouse model of peripheral artery disease
Choi, J., Kim, N. G., Kong, D., Kim, M., Kang, B.-C., Kwon, D., Kim, D., & Kang, K. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04554-5 · Cited by 12
Chimeric Antigen Receptors and Regulatory T Cells: The Potential for HLA-Specific Immunosuppression in Transplantation
Wright, S., Hennessy, C., Hester, J., & Issa, F. (2021) · Engineering · doi:10.1016/j.eng.2021.10.018 · Cited by 11
Fabricating 3-dimensional human brown adipose microtissues for transplantation studies
Wang, O., Li, H., Lin, H., Tian, M., Zhang, S., Duan, B., Chung, S., Zhang, C., Lian, X. L., Wang, Y., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.10.022 · Cited by 12
Enhanced survival of hypoimmunogenic otic progenitors following intracochlear xenotransplantation: repercussions for stem cell therapy in hearing loss models
da Silva, L. H. A., Heuer, R. A., Roque, C. B., Mcguire, T. L., Hosoya, T., Kimura, H., Tamura, K., & Matsuoka, A. (2023) · Stem cell research & therapeutics · doi:10.1186/s13287-023-03304-9 · Cited by 9
CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice
Ma, C., Cao, H., Sun, Z., Deng, Q., Liu, W., Xin, Y., Qiao, S., Cen, J., Shu, Y., Qi, K., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.07.020 · Cited by 10
Human Leukocyte Antigen Class I Pseudo-Homozygous Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells
Kwon, D., Ahn, H.-J., Han, M.-J., Ji, M., Ahn, J., Seo, K., & Kang, K. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09990-9 · Cited by 10
Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development
Feng, L., Wang, Y., Fu, Y., Li, T., & He, G. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10672-5 · Cited by 9
Large animal models for cardiac remuscularization studies: A methodological review
Yu, Y., Tham, S. K., Roslan, F. F., Shaharuddin, B., Yong, Y. K., Zhikun, G., & Tan, J. J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1011880 · Cited by 9
Replacing renal function using bioengineered tissues
Little, M., & Rabelink, T. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00066-0 · Cited by 7
High-throughput CRISPR technology: a novel horizon for solid organ transplantation
Li, X., Chen, Z., Ye, W., Yu, J., Zhang, X., Li, Y., Niu, Y., Ran, S., Wang, S., Luo, Z., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295523 · Cited by 10

Authors: Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., Davis, M. M., Lanier, L. L., & Schrepfer, S.
Affiliations: University of California, San Francisco (US)
Universität Hamburg (DE)
University of North Carolina at Chapel Hill (US)
Howard Hughes Medical Institute (US)
Corresponding author: Schrepfer, Sonja
ORCID: Deuse, Tobias
Hu, Xiaomeng
Gravina, Alessia
Wang, Dong
Tediashvili, Grigol
De, Chandrav
Wahl, Angela
Davis, Mark M.
Lanier, Lewis L.
Schrepfer, Sonja
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2019-02-18
Volume: 37
Issue: 3
Pages: 252-258
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/s41587-019-0016-3
PMC: PMC6419516
OpenAlex: W2911604931
Cited by: 758
References: 31
Citations by year: 2026: 98 · 2025: 102 · 2024: 102 · 2023: 113 · 2022: 94 · 2021: 97 · 2020: 106 · 2019: 46
FWCI: 28.36
Type: journal article
Language: en
Update notices: correction (2022-09-16)
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL140236)
National Institute of Mental Health (R01MH108179)
National Institute of Allergy and Infectious Diseases (R01AI068129, R01AI111899, R01AI123010, U19AI057229)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords: induced pluripotent stem cells, immune rejection, allogeneic transplantation, MHC mismatch, endothelial cells, smooth muscle cells, cardiomyocytes, immunosuppression-free transplantation
MeSH terms: Animals, Cell Differentiation, Graft Rejection, HLA Antigens, Humans, Transplantation, Homologous, Histocompatibility Antigens Class I, Myocytes, Cardiac, Mice, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks